Director's Dealing • Aug 17, 2020
Director's Dealing
Open in ViewerOpens in native device viewer

Pursuant to Article 19 of Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (market abuse regulation) and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016, Novozymes hereby publishes the following transactions under ISIN code DK0060336014, Novozymes B shares (ticker symbol NZYM B). This sale has been conducted pursuant to Novo Holdings A/S' previously announced intention, to maintain its relative holding of approximately 25.5% of the total shares which was the level prior to Novozymes' reduction of shares on March 27, 2020 (company announcement no. 20, 2020).
Today, Novozymes has entered into an agreement to purchase 765,000 B shares (nominal DKK 2.00) of a value of DKK 279,706,950 from Novo Holdings A/S. This transaction is part of Novozymes' 2020 share repurchase programme of up to a total of DKK 1.5 billion to be executed during 2020. The transaction price is DKK 365.63 per share and has been calculated as the volume weighted average market price from August 13 to 17, 2020 in the open window following the announcement of Novozymes' financial results for the first half of 2020.
August 17, 2020 Company announcement No. 51
Contact information [email protected]
Tobias Cornelius Björklund +45 3077 8682 [email protected]
Carl Ahlgren +1 919 702 6144 [email protected]
Ulrik Wu Svare +45 3077 3187 [email protected]
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Name Novo Holdings A/S
| Reason for notification | |
|---|---|
| Position/status | The CEO of Novo Holdings A/S serves on the Board of Directors of Novozymes A/S, and |
| thus, Novo Holdings A/S is a related party of Novozymes A/S | |
| Initial notification/ | Initial notification |
| amendment |
| Entity | Novozymes A/S |
|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
| Description: | ||||
|---|---|---|---|---|
| Financial instrument | Shares | |||
| Identification code | ISIN DK0060336014 | |||
| Nature of the transaction | Sale of shares | |||
| Place(s) of transaction(s), | ||||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) | |
| Outside a trading venue | 365.63 DKK | 765,000 shares | ||
| Aggregated information | Number of shares: 765,000 | |||
| Average price, DKK: 365.63 | ||||
| Transaction value, DKK: 279,706,950 | ||||
| Date of the transaction | 2020-08-17 |

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.